Global Alpha-1 Lung Disease Market Growth (Status and Outlook) 2021-2026

Global Alpha-1 Lung Disease Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alpha-1 Lung Disease Market Size 2016-2026
2.1.2 Alpha-1 Lung Disease Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Alpha-1 Lung Disease Segment by Indication
2.2.1 Augmentation Therapy
2.2.2 Augmentation Therapy
2.2.3 Non-CF Bronchiectasis(NCFB)
2.2.4 Other
2.3 Alpha-1 Lung Disease Market Size by Indication
2.3.1 Global Alpha-1 Lung Disease Market Size CAGR by Indication
2.3.2 Global Alpha-1 Lung Disease Market Size Market Share by Indication (2016-2021)
2.4 Alpha-1 Lung Disease Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Pharmacies
2.4.4 Others
2.5 Alpha-1 Lung Disease Market Size by Application
2.5.1 Global Alpha-1 Lung Disease Market Size CAGR by Application
2.5.2 Global Alpha-1 Lung Disease Market Size Market Share by Application (2016-2021)

3 Alpha-1 Lung Disease Market Size by Players
3.1 Alpha-1 Lung Disease Market Size Market Share by Players
3.1.1 Global Alpha-1 Lung Disease Revenue by Players (2019-2021E)
3.1.2 Global Alpha-1 Lung Disease Revenue Market Share by Players (2019-2021E)
3.2 Global Alpha-1 Lung Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Alpha-1 Lung Disease by Regions
4.1 Alpha-1 Lung Disease Market Size by Regions (2016-2021)
4.2 Americas Alpha-1 Lung Disease Market Size Growth (2016-2021)
4.3 APAC Alpha-1 Lung Disease Market Size Growth (2016-2021)
4.4 Europe Alpha-1 Lung Disease Market Size Growth (2016-2021)
4.5 Middle East & Africa Alpha-1 Lung Disease Market Size Growth (2016-2021)

5 Americas
5.1 Americas Alpha-1 Lung Disease Market Size by Country (2016-2021)
5.2 Americas Alpha-1 Lung Disease Market Size by Indication (2016-2021)
5.3 Americas Alpha-1 Lung Disease Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Alpha-1 Lung Disease Market Size by Region (2016-2021)
6.2 APAC Alpha-1 Lung Disease Market Size by Indication (2016-2021)
6.3 APAC Alpha-1 Lung Disease Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Alpha-1 Lung Disease by Country (2016-2021)
7.2 Europe Alpha-1 Lung Disease Market Size by Indication (2016-2021)
7.3 Europe Alpha-1 Lung Disease Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Alpha-1 Lung Disease by Region (2016-2021)
8.2 Middle East & Africa Alpha-1 Lung Disease Market Size by Indication (2016-2021)
8.3 Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Alpha-1 Lung Disease Market Forecast
10.1 Global Alpha-1 Lung Disease Forecast by Regions (2021-2026)
10.1.1 Global Alpha-1 Lung Disease Forecast by Regions (2021-2026)
10.1.2 Americas Alpha-1 Lung Disease Forecast
10.1.3 APAC Alpha-1 Lung Disease Forecast
10.1.4 Europe Alpha-1 Lung Disease Forecast
10.1.5 Middle East & Africa Alpha-1 Lung Disease Forecast
10.2 Americas Alpha-1 Lung Disease Forecast by Countries (2021-2026)
10.2.1 United States Alpha-1 Lung Disease Market Forecast
10.2.2 Canada Alpha-1 Lung Disease Market Forecast
10.2.3 Mexico Alpha-1 Lung Disease Market Forecast
10.2.4 Brazil Alpha-1 Lung Disease Market Forecast
10.3 APAC Alpha-1 Lung Disease Forecast by Region (2021-2026)
10.3.1 China Alpha-1 Lung Disease Market Forecast
10.3.2 Japan Alpha-1 Lung Disease Market Forecast
10.3.3 Korea Alpha-1 Lung Disease Market Forecast
10.3.4 Southeast Asia Alpha-1 Lung Disease Market Forecast
10.3.5 India Alpha-1 Lung Disease Market Forecast
10.3.6 Australia Alpha-1 Lung Disease Market Forecast
10.4 Europe Alpha-1 Lung Disease Forecast by Country (2021-2026)
10.4.1 Germany Alpha-1 Lung Disease Market Forecast
10.4.2 France Alpha-1 Lung Disease Market Forecast
10.4.3 UK Alpha-1 Lung Disease Market Forecast
10.4.4 Italy Alpha-1 Lung Disease Market Forecast
10.4.5 Russia Alpha-1 Lung Disease Market Forecast
10.5 Middle East & Africa Alpha-1 Lung Disease Forecast by Region (2021-2026)
10.5.1 Egypt Alpha-1 Lung Disease Market Forecast
10.5.2 South Africa Alpha-1 Lung Disease Market Forecast
10.5.3 Israel Alpha-1 Lung Disease Market Forecast
10.5.4 Turkey Alpha-1 Lung Disease Market Forecast
10.5.5 GCC Countries Alpha-1 Lung Disease Market Forecast
10.6 Global Alpha-1 Lung Disease Forecast by Indication (2021-2026)
10.7 Global Alpha-1 Lung Disease Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Alpha-1 Lung Disease Product Offered
11.1.3 Pfizer Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Alpha-1 Lung Disease Product Offered
11.2.3 Baxter Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Baxter Main Business Overview
11.2.5 Baxter Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Alpha-1 Lung Disease Product Offered
11.3.3 AstraZeneca Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Grifols
11.4.1 Grifols Company Information
11.4.2 Grifols Alpha-1 Lung Disease Product Offered
11.4.3 Grifols Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Grifols Main Business Overview
11.4.5 Grifols Latest Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Information
11.5.2 Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered
11.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Teva Pharmaceutical Industries Main Business Overview
11.5.5 Teva Pharmaceutical Industries Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Alpha-1 Lung Disease Product Offered
11.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Information
11.7.2 Kamada Ltd Alpha-1 Lung Disease Product Offered
11.7.3 Kamada Ltd Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Kamada Ltd Main Business Overview
11.7.5 Kamada Ltd Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Alpha-1 Lung Disease Product Offered
11.8.3 GlaxoSmithKline Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 CSL Behring
11.9.1 CSL Behring Company Information
11.9.2 CSL Behring Alpha-1 Lung Disease Product Offered
11.9.3 CSL Behring Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 CSL Behring Main Business Overview
11.9.5 CSL Behring Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Alpha-1 Lung Disease Product Offered
11.10.3 Takeda Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11. LFB Biomedicaments
11.11.1 LFB Biomedicaments Company Information
11.11.2 LFB Biomedicaments Alpha-1 Lung Disease Product Offered
11.11.3 LFB Biomedicaments Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 LFB Biomedicaments Main Business Overview
11.11.5 LFB Biomedicaments Latest Developments
11.12 Abeona Therapeutics
11.12.1 Abeona Therapeutics Company Information
11.12.2 Abeona Therapeutics Alpha-1 Lung Disease Product Offered
11.12.3 Abeona Therapeutics Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Abeona Therapeutics Main Business Overview
11.12.5 Abeona Therapeutics Latest Developments
11.13 Biogen
11.13.1 Biogen Company Information
11.13.2 Biogen Alpha-1 Lung Disease Product Offered
11.13.3 Biogen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Biogen Main Business Overview
11.13.5 Biogen Latest Developments
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Information
11.14.2 Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered
11.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Vertex Pharmaceuticals Main Business Overview
11.14.5 Vertex Pharmaceuticals Latest Developments
11.15 Baxalta
11.15.1 Baxalta Company Information
11.15.2 Baxalta Alpha-1 Lung Disease Product Offered
11.15.3 Baxalta Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Baxalta Main Business Overview
11.15.5 Baxalta Latest Developments
11.16 Arrowhead Research Corporation
11.16.1 Arrowhead Research Corporation Company Information
11.16.2 Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered
11.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Arrowhead Research Corporation Main Business Overview
11.16.5 Arrowhead Research Corporation Latest Developments
11.17 ProBioGen
11.17.1 ProBioGen Company Information
11.17.2 ProBioGen Alpha-1 Lung Disease Product Offered
11.17.3 ProBioGen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 ProBioGen Main Business Overview
11.17.5 ProBioGen Latest Developments
11.18 Chiesi Pharmaceuticals
11.18.1 Chiesi Pharmaceuticals Company Information
11.18.2 Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered
11.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Chiesi Pharmaceuticals Main Business Overview
11.18.5 Chiesi Pharmaceuticals Latest Developments
11.19 Kedrion Group
11.19.1 Kedrion Group Company Information
11.19.2 Kedrion Group Alpha-1 Lung Disease Product Offered
11.19.3 Kedrion Group Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Kedrion Group Main Business Overview
11.19.5 Kedrion Group Latest Developments
11.20 ProMetic Life Sciences
11.20.1 ProMetic Life Sciences Company Information
11.20.2 ProMetic Life Sciences Alpha-1 Lung Disease Product Offered
11.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 ProMetic Life Sciences Main Business Overview
11.20.5 ProMetic Life Sciences Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Alpha-1 Lung Disease Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Augmentation Therapy
Table 3. Major Players of Cystic Fibrosis(CF)
Table 4. Major Players of Non-CF Bronchiectasis(NCFB)
Table 5. Major Players of Other
Table 6. Alpha-1 Lung Disease Market Size CAGR by Indication (2020-2026) & ($ Millions)
Table 7. Global Alpha-1 Lung Disease Market Size by Indication (2016-2021) & ($ Millions)
Table 8. Global Alpha-1 Lung Disease Market Size Market Share by Indication (2016-2021)
Table 9. Alpha-1 Lung Disease Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Alpha-1 Lung Disease Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Alpha-1 Lung Disease Market Size Market Share by Application (2016-2021)
Table 12. Global Alpha-1 Lung Disease Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Alpha-1 Lung Disease Revenue Market Share by Players (2019-2021E)
Table 14. Alpha-1 Lung Disease Key Players Head office and Products Offered
Table 15. Alpha-1 Lung Disease Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Alpha-1 Lung Disease Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Alpha-1 Lung Disease Market Size Market Share by Regions 2016-2021
Table 20. Americas Alpha-1 Lung Disease Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Alpha-1 Lung Disease Market Size Market Share by Country (2016-2021)
Table 22. Americas Alpha-1 Lung Disease Market Size by Indication (2016-2021) & ($ Millions)
Table 23. Americas Alpha-1 Lung Disease Market Size Market Share by Indication (2016-2021)
Table 24. Americas Alpha-1 Lung Disease Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Alpha-1 Lung Disease Market Size Market Share by Application (2016-2021)
Table 26. APAC Alpha-1 Lung Disease Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Alpha-1 Lung Disease Market Size Market Share by Region (2016-2021)
Table 28. APAC Alpha-1 Lung Disease Market Size by Indication (2016-2021) & ($ Millions)
Table 29. APAC Alpha-1 Lung Disease Market Size Market Share by Indication (2016-2021)
Table 30. APAC Alpha-1 Lung Disease Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Alpha-1 Lung Disease Market Size Market Share by Application (2016-2021)
Table 32. Europe Alpha-1 Lung Disease Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Alpha-1 Lung Disease Market Size Market Share by Country (2016-2021)
Table 34. Europe Alpha-1 Lung Disease Market Size by Indication (2016-2021) & ($ Millions)
Table 35. Europe Alpha-1 Lung Disease Market Size Market Share by Indication (2016-2021)
Table 36. Europe Alpha-1 Lung Disease Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Alpha-1 Lung Disease Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Alpha-1 Lung Disease Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Alpha-1 Lung Disease Market Size by Indication (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Indication (2016-2021)
Table 42. Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Alpha-1 Lung Disease
Table 45. Key Application and Potential Industries of Alpha-1 Lung Disease
Table 46. Key Challenges of Alpha-1 Lung Disease
Table 47. Key Trends of Alpha-1 Lung Disease
Table 48. Global Alpha-1 Lung Disease Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Alpha-1 Lung Disease Market Size Forecast by Indication (2021-2026) & ($ Millions)
Table 51. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Indication (2021-2026)
Table 52. Global Alpha-1 Lung Disease Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Application (2021-2026)
Table 54. Pfizer Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 55. Pfizer Alpha-1 Lung Disease Product Offered
Table 56. Pfizer Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Pfizer Main Business
Table 58. Pfizer Latest Developments
Table 59. Baxter Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 60. Baxter Alpha-1 Lung Disease Product Offered
Table 61. Baxter Main Business
Table 62. Baxter Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Baxter Latest Developments
Table 64. AstraZeneca Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 65. AstraZeneca Alpha-1 Lung Disease Product Offered
Table 66. AstraZeneca Main Business
Table 67. AstraZeneca Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. AstraZeneca Latest Developments
Table 69. Grifols Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 70. Grifols Alpha-1 Lung Disease Product Offered
Table 71. Grifols Main Business
Table 72. Grifols Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. Grifols Latest Developments
Table 74. Teva Pharmaceutical Industries Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 75. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered
Table 76. Teva Pharmaceutical Industries Main Business
Table 77. Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Teva Pharmaceutical Industries Latest Developments
Table 79. Boehringer Ingelheim Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 80. Boehringer Ingelheim Alpha-1 Lung Disease Product Offered
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Boehringer Ingelheim Latest Developments
Table 84. Kamada Ltd Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 85. Kamada Ltd Alpha-1 Lung Disease Product Offered
Table 86. Kamada Ltd Main Business
Table 87. Kamada Ltd Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Kamada Ltd Latest Developments
Table 89. GlaxoSmithKline Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 90. GlaxoSmithKline Alpha-1 Lung Disease Product Offered
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. GlaxoSmithKline Latest Developments
Table 94. CSL Behring Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 95. CSL Behring Alpha-1 Lung Disease Product Offered
Table 96. CSL Behring Main Business
Table 97. CSL Behring Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. CSL Behring Latest Developments
Table 99. Takeda Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 100. Takeda Alpha-1 Lung Disease Product Offered
Table 101. Takeda Main Business
Table 102. Takeda Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. Takeda Latest Developments
Table 104. LFB Biomedicaments Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 105. LFB Biomedicaments Alpha-1 Lung Disease Product Offered
Table 106. LFB Biomedicaments Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. LFB Biomedicaments Main Business
Table 108. LFB Biomedicaments Latest Developments
Table 109. Abeona Therapeutics Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 110. Abeona Therapeutics Alpha-1 Lung Disease Product Offered
Table 111. Abeona Therapeutics Main Business
Table 112. Abeona Therapeutics Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. Abeona Therapeutics Latest Developments
Table 114. Biogen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 115. Biogen Alpha-1 Lung Disease Product Offered
Table 116. Biogen Main Business
Table 117. Biogen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 118. Biogen Latest Developments
Table 119. Vertex Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 120. Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered
Table 121. Vertex Pharmaceuticals Main Business
Table 122. Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 123. Vertex Pharmaceuticals Latest Developments
Table 124. Baxalta Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 125. Baxalta Alpha-1 Lung Disease Product Offered
Table 126. Baxalta Main Business
Table 127. Baxalta Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 128. Baxalta Latest Developments
Table 129. Arrowhead Research Corporation Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 130. Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered
Table 131. Arrowhead Research Corporation Main Business
Table 132. Arrowhead Research Corporation Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 133. Arrowhead Research Corporation Latest Developments
Table 134. ProBioGen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 135. ProBioGen Alpha-1 Lung Disease Product Offered
Table 136. ProBioGen Main Business
Table 137. ProBioGen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 138. ProBioGen Latest Developments
Table 139. Chiesi Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 140. Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered
Table 141. Chiesi Pharmaceuticals Main Business
Table 142. Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 143. Chiesi Pharmaceuticals Latest Developments
Table 144. Kedrion Group Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 145. Kedrion Group Alpha-1 Lung Disease Product Offered
Table 146. Kedrion Group Main Business
Table 147. Kedrion Group Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 148. Kedrion Group Latest Developments
Table 149. ProMetic Life Sciences Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 150. ProMetic Life Sciences Alpha-1 Lung Disease Product Offered
Table 151. ProMetic Life Sciences Main Business
Table 152. ProMetic Life Sciences Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 153. ProMetic Life Sciences Latest Developments
List of Figures
Figure 1. Alpha-1 Lung Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alpha-1 Lung Disease Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Alpha-1 Lung Disease Market Size Market Share by Indication in 2020
Figure 7. Alpha-1 Lung Disease in Hospitals
Figure 8. Global Alpha-1 Lung Disease Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Alpha-1 Lung Disease in Specialty Clinics
Figure 10. Global Alpha-1 Lung Disease Market: Specialty Clinics (2016-2021) & ($ Millions)
Figure 11. Alpha-1 Lung Disease in Pharmacies
Figure 12. Global Alpha-1 Lung Disease Market: Pharmacies (2016-2021) & ($ Millions)
Figure 13. Alpha-1 Lung Disease in Others
Figure 14. Global Alpha-1 Lung Disease Market: Others (2016-2021) & ($ Millions)
Figure 15. Global Alpha-1 Lung Disease Market Size Market Share by Application in 2020
Figure 16. Global Alpha-1 Lung Disease Revenue Market Share by Player in 2020
Figure 17. Global Alpha-1 Lung Disease Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Alpha-1 Lung Disease Market Size 2016-2021 ($ Millions)
Figure 19. APAC Alpha-1 Lung Disease Market Size 2016-2021 ($ Millions)
Figure 20. Europe Alpha-1 Lung Disease Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Alpha-1 Lung Disease Market Size 2016-2021 ($ Millions)
Figure 22. Americas Alpha-1 Lung Disease Market Size Market Share by Country in 2020
Figure 23. Americas Alpha-1 Lung Disease Market Size Market Share by Indication in 2020
Figure 24. Americas Alpha-1 Lung Disease Market Size Market Share by Application in 2020
Figure 25. United States Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Alpha-1 Lung Disease Market Size Market Share by Regions in 2020
Figure 29. APAC Alpha-1 Lung Disease Market Size Market Share by Indication in 2020
Figure 30. APAC Alpha-1 Lung Disease Market Size Market Share by Application in 2020
Figure 31. China Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Alpha-1 Lung Disease Market Size Market Share by Country in 2020
Figure 38. Europe Alpha-1 Lung Disease Market Size Market Share by Indication in 2020
Figure 39. Europe Alpha-1 Lung Disease Market Size Market Share by Application in 2020
Figure 40. Germany Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Indication in 2020
Figure 47. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application in 2020
Figure 48. Egypt Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Alpha-1 Lung Disease Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 54. APAC Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 55. Europe Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 57. United States Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 58. Canada Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 61. China Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 62. Japan Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 63. Korea Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 65. India Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 66. Australia Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 67. Germany Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 68. France Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 69. UK Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 70. Italy Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 71. Russia Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 72. Spain Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 75. Israel Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Alpha-1 Lung Disease Market Size 2021-2026 ($ Millions)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs